caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1336313899

Rebecca PatelMD, MPH

Internal MedicineBoston, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
1,592
Beneficiaries
—
Total drug cost
$216K
Distinct drugs
49
Brand share
19.8%
Top prescribed drugs
Atorvastatin Calcium106 claims
Oxycodone Hcl87 claims
Rosuvastatin Calcium81 claims
Omeprazole72 claims
Semaglutide62 claims
REFERRAL NETWORK

Where Rebecca Patel's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE GENERAL HOSPITAL CORPORATION42554
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NORTH END COMMUNITY HEALTH COMMITTEE INC51502
THE GENERAL HOSPITAL CORPORATION36348
John Foster
Internal Medicine · Boston, MA
1138
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
151
Unique beneficiaries
—
Total services
223
Distinct HCPCS
5
Medicare payment
$7K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,978 Internal Medicine providers in MA — below median (cohort median 564).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.